Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

Literature DB >> 6017527

Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

V Parsons, M Baum, M Self.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1967 PMID： 6017527 PMCID： PMC1840856 DOI： 10.1136/bmj.1.5538.474

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

20 in total

1. URINARY HYDROXYPROLINE EXCRETION IN METASTATIC CANCER OF BONE.

Authors: W D PLATT; L H DOOLITTLE; J W HARTSHORN
Journal: N Engl J Med Date: 1964-08 Impact factor: 91.245

2. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS.

Authors: J H BROWN; B J KENNEDY
Journal: N Engl J Med Date: 1965-01-21 Impact factor: 91.245

3. THE EFFECT OF PREDNISONE ON CALCIUM METABOLISM AND CA47 KINETICS IN PATIENTS WITH MULTIPLE MYELOMA AND HYPERCALCEMIA.

Authors: C J BENTZEL; P P CARBONE; L ROSENBERG
Journal: J Clin Invest Date: 1964-11 Impact factor: 14.808

4. CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.

Authors: L KLEIN; F W LAFFERTY; O H PEARSON; P H CURTISS
Journal: Metabolism Date: 1964-03 Impact factor: 8.694

5. Assessment of calcium excretion from the urinary calcium/creatinine ratio.

Authors: B E NORDIN
Journal: Lancet Date: 1959-09-19 Impact factor: 79.321

Review 6. Mode of action of antibiotics. II. Drugs affecting nucleic acid and protein synthesis.

Authors: I H Goldberg
Journal: Am J Med Date: 1965-11 Impact factor: 4.965

7. [Urinary hydroxyproline during secondary bone cancers].

Authors: M Gruson; A Ryckewaert; D Hioco; C Lanham; S de Sèze
Journal: Pathol Biol Date: 1966-02

8. Urinary hydroxyproline and calcium metabolism in patients with cancer.

Authors: G Bonadonna; M J Merlino; W P Myers; M Sonenberg
Journal: N Engl J Med Date: 1966-08-11 Impact factor: 91.245

9. Actinomycin D Inhibition of Vitamin D Action.

Authors: J E Zull; E Czarnowska-Misztal; H F Deluca
Journal: Science Date: 1965-07-09 Impact factor: 47.728

10. ACTINOMYCIN D AND THE RESPONSE TO PARATHYROID HORMONE.

Authors: H RASMUSSEN; C ARNAUD; C HAWKER
Journal: Science Date: 1964-05-22 Impact factor: 47.728

16 in total

Review 1. The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors: D B Lee; E T Zawada; C R Kleeman
Journal: West J Med Date: 1978-10

2. Inhibition of parathyroid hormone stimulated bone resorption in vitro by the antibiotic mithramycin.

Authors: C Minkin
Journal: Calcif Tissue Res Date: 1973-12-31

3. Control of hypercalcemia with mithramycin.

Authors: E G Ellas; G Reynoso; A Mittelman
Journal: Ann Surg Date: 1972-03 Impact factor: 12.969

4. Clinical and biochemical studies of Paget's disease of bone with emphasis on the effects of RNA inhibitors actinomycin D and mithrawycin.

Authors: J J Fennelly
Journal: Ir J Med Sci Date: 1971-10 Impact factor: 1.568